Federal contractor · PISCATAWAY, NJ

GENSCRIPT USA INC

GENSCRIPT USA INC received $971.1K in federal contract obligations in FY2026, on 25 awards (−38% vs FY2025). Since FY2017: $22M. Its largest customer was National Institutes of Health ($958.3K).

Obligations · FY2026
$971.1K
New awards
25
Sole-source
0.0%
Single offer
1.6%
UEI
KVLBRRAQ6UX1
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 1.6MFY2017
  2. 836.6KFY2018
  3. 3.1MFY2019
  4. 1.8MFY2020
  5. 4.2MFY2021
  6. 3.2MFY2022
  7. 3.1MFY2023
  8. 1.7MFY2024
  9. 1.6MFY2025
  10. 971.1KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$958.3K99%
    20 awards
  2. Agricultural Research Service$12.8K1.3%
    3 awards
  3. Food and Drug Administration-$6.680.0%
    2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$980.4K100%

Where the work was performed

  1. Middlesex County, NJ$986.8K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · -$50.5K
  • Sole-source awards0.0%
    US 30% · -$66K
  • Single-offer competitions1.6%
    US 8.8% · $15.5K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB)$3.1M
    National Institutes of Health· Middlesex County, NJ· Health & medical· Sep 6, 2024 – Sep 24, 2026· 75N91024P00630
  2. PEPTIDE SYNTHESIS SPANNING ENTIRE TB PROTEOME$1.4M
    National Institutes of Health· Middlesex County, NJ· Health & medical· Sep 23, 2021 – Sep 1, 2026· 75N93021P01485
  3. GENE PRODUCTION AND PROTEIN EXPRESSION SERVICES CUSTOM DESC: GENE SYNTHESIS, CLONING, PLASMID PREP, PROTEIN EXPRESSION AND PURIFICATION.$249.2K
    National Institutes of Health· Middlesex County, NJ· Health & medical· Aug 27, 2023 – Apr 15, 2026· 75N93023P01146
  4. GENE SYNTHESIS AND PROTEIN PRODUCTION (AMBIS #2136137)$156.4K
    National Institutes of Health· Middlesex County, NJ· Health & medical· Aug 31, 2022 – Apr 24, 2026· 75N93022P01112
  5. EXPRESS PLASMID PREPARATION, EXPRESS MUTAGENESIS TARGET AND CLONEARK PLASMID PREPARATION$141.4K
    National Institutes of Health· Montgomery County, MD· Health & medical· Sep 13, 2021 – Aug 31, 2026· 75N93021P01399
  6. PROTEIN ANTIGEN PRODUCTION SERVICES FOR INFLUENZA VACCINE$123.9K
    National Institutes of Health· Middlesex County, NJ· Health & medical· Sep 22, 2021 – Sep 1, 2026· 75N93021P01486
  7. GENSCRIPT USA INCOPORATED MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES$96.6K
    National Institutes of Health· Middlesex County, NJ· Health & medical· Aug 26, 2024 – Apr 28, 2026· 75N93024P01055
  8. GENSCRIPT MONOCLONAL ANTIBODIES AND PLASMID SERVICES (AMBIS #2231021)$77K
    National Institutes of Health· Middlesex County, NJ· Health & medical· Aug 22, 2024 – May 1, 2026· 75N93024P01043

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 9 markets (agency × industry), FY2024–FY2026.

  1. PSOMAGEN INC$4.5M−77% in FY2026
    ROCKVILLE, MD · 82% of this company's obligations are in markets they both serveNational Institutes of Health · Medical and diagnostic laboratoriesNational Institutes of Health · Architectural, engineering, and related servicesAgricultural Research Service · Scientific research and development services
  2. NATIONAL MEDICAL SERVICES, INC.$2M+13% in FY2026
    HORSHAM, PA · 39% of this company's obligations are in markets they both serveNational Institutes of Health · Medical and diagnostic laboratoriesNational Institutes of Health · Architectural, engineering, and related services
  3. AMPRION, INC.$1.1M−100% in FY2026
    SAN FRANCISCO, CA · 26% of this company's obligations are in markets they both serveNational Institutes of Health · Medical and diagnostic laboratories

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.